Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable/Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01763164
What this trial is testing

Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma

Who this might be right for
Metastatic or Unresectable Cutaneous Melanoma
Pfizer 402
Testing effectiveness (Phase 2)Ended earlyNCT01082887
What this trial is testing

Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg)

Who this might be right for
Metastatic Melanoma
Nantes University Hospital 18
Not applicableStudy completedNCT02310451
What this trial is testing

Study of Molecular Mechanisms Implicated in the Pathogenesis of Melanoma. Role of Exosomes

Who this might be right for
Metastatic Melanoma
Centre Hospitalier Universitaire de Nice 15
Not applicableLooking for participantsNCT07302607
What this trial is testing

Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021

Who this might be right for
Stage III Melanoma
University Hospital, Strasbourg, France 221
Not applicableStudy completedNCT02780089
What this trial is testing

Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study

Who this might be right for
Melanoma
Bristol-Myers Squibb 408
Testing effectiveness (Phase 2)Study completedNCT03484923
What this trial is testing

Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
Novartis Pharmaceuticals 196
Testing effectiveness (Phase 2)Study completedNCT01302496
What this trial is testing

Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Bart Neyns 39
Not applicableAvailableNCT05398640
What this trial is testing

Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

Who this might be right for
Unresectable MelanomaMetastatic Melanoma
Iovance Biotherapeutics, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Testing effectiveness (Phase 2)UnknownNCT03269565
What this trial is testing

International Trial of the Efficacy and Safety of BCD-100 in Patients With Melanoma

Who this might be right for
Melanoma
Biocad 126
Testing effectiveness (Phase 2)Ended earlyNCT01942993
What this trial is testing

The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma

Who this might be right for
Melanoma
Philip Friedlander 3
Early research (Phase 1)Study completedNCT06108479
What this trial is testing

Study of DF6215 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultSolid Tumor Cancer
Dragonfly Therapeutics 35
Testing effectiveness (Phase 2)Study completedNCT05420324
What this trial is testing

Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
Eucure (Beijing) Biopharma Co., Ltd 20
Early research (Phase 1)Study completedNCT01910181
What this trial is testing

Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631325
What this trial is testing

Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma

Who this might be right for
Unresectable Cutaneous Melanoma
John Kirkwood 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT01134614
What this trial is testing

Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Advanced MelanomaMetastatic MelanomaRecurrent Melanoma+6 more
National Cancer Institute (NCI) 245
Not applicableStudy completedNCT05260684
What this trial is testing

Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the US

Who this might be right for
Melanoma
Pfizer 716
Large-scale testing (Phase 3)Study completedNCT01721772
What this trial is testing

Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 418
Testing effectiveness (Phase 2)Study completedNCT02275416
What this trial is testing

Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma

Who this might be right for
Malignant Melanoma
Ultimovacs ASA 12
Large-scale testing (Phase 3)Looking for participantsNCT05727904
What this trial is testing

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Who this might be right for
Metastatic MelanomaUnresectable MelanomaMelanoma
Iovance Biotherapeutics, Inc. 670
Next Page